The Penn Brain Tumor Center consists of a multidisciplinary team of specialists who provide personalized treatment and cutting-edge therapy for benign and malignant brain tumors. With top-ranked cancer and neurosurgery clinicians and scientists, the Penn Brain Tumor Center offers the most complete spectrum of care for patients with brain tumors in the Philadelphia region. Available treatment options include:
- Neuromonitoring, including awake craniotomy, language and motor mapping
- MR-guided surgery with diffusion tractography to detect fiber tracts
- Personalized medicine with molecular profiling of brain tumors
- CyberKnife®
- Gamma Knife®
- Proton therapy
- Clinical trials
- Intensity-modulated radiation therapy (IMRT)
- Advanced neurosurgery for complex and “inoperable” brain tumors
- Endoscopic approaches to skull-base tumors
The Penn Brain Tumor Center is translating research into new therapeutics to treat brain tumors, including personalized drug, vaccine and molecular targeted therapies. In addition, as an active member of the National Cancer Institute’s Adult Brain Tumor Consortium (ABTC), the Center offers patients access to clinical trials that are not available anywhere else in the region.
The Penn Brain Tumor Center has been recognized by the American Brain Tumor Association for providing the highest quality care and advancing understanding and treatment of brain cancer.
From translational research to cutting edge clinical trials and the latest treatment options, the Penn Brain Tumor Center is committed to providing exceptional care to patients with brain tumors.
